SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-260814
Filing Date
2023-10-23
Accepted
2023-10-23 16:13:55
Documents
12
Period of Report
2023-10-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d559319d8k.htm   iXBRL 8-K 50338
  Complete submission text file 0001193125-23-260814.txt   175910

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amam-20231022.xsd EX-101.SCH 2846
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20231022_lab.xml EX-101.LAB 17980
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20231022_pre.xml EX-101.PRE 11256
6 EXTRACTED XBRL INSTANCE DOCUMENT d559319d8k_htm.xml XML 3356
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56600 | Film No.: 231340127
SIC: 2836 Biological Products, (No Diagnostic Substances)